Background illustration for clinical trials search

Paid Clinical Trials Rochester

Discover 998 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

for
Ovarian Cancer
Location: Rochester MN, Cleveland OH, Charleston WV, York PA,
Sponsor: NX Development Corp

Sex: Female

Age: 18+

Code: NCT05804370

Phase3, Recruiting

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

for
SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors,
Location: Rochester MN, Detroit MI, Lexington KY, Aurora CO,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07129252

Phase1, Phase2, Recruiting

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

for
Breast Cancer
Location: Rochester MN, Omaha NE, Fairfax VA, Houston TX,
Sponsor: Biotheryx, Inc.

Sex: All

Age: 18+

Code: NCT06515470

Phase1, Recruiting

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

for
Multiple System Atrophy
Location: Rochester MN, Chicago IL, Kansas City KS,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 30 - 70+

Code: NCT06568237

Phase2, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Rochester MN, Omaha NE, Kansas City KS, Indianapolis IN,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Comparing Use of Incentive Spirometry With and Without Reminder

for
Post Operative
Location: Rochester MN, New Brunswick NJ
Sponsor: Tidal Medical Technologies

Sex: All

Age: 18+

Code: NCT06101030

Recruiting

A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus

for
Lichen Sclerosus
Location: Rochester MN, Winnipeg, Bexley OH, Guelph, Newmarket,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT07335588

Phase3, Recruiting

Transition to KPL-387 Monotherapy Dosing & Administration Study

for
Recurrent Pericarditis, Heart Diseases, Pericarditis
Location: Rochester MN, Chicago IL, St Louis MO, Cincinnati OH,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07288216

Phase2, Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

for
Non-obstructive Hypertrophic Cardiomyopathy
Location: Rochester MN, Chicago IL, Grand Rapids MI, St Louis MO,
Sponsor: Imbria Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07023614

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

for
Amyloidosis
Location: Rochester MN
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07224672

Phase2, Recruiting

Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387

for
Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Location: Rochester MN, Minneapolis MN, Chicago IL,
Sponsor: Kiniksa Pharmaceuticals International, plc

Sex: All

Age: 18 - 70+

Code: NCT07010159

Phase2, Phase3, Recruiting

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

for
Neoplasms, Prostate
Location: Rochester MN, Nashville TN, Toronto, Denver CO,
Sponsor: GlaxoSmithKline

Sex: Male

Age: 18+

Code: NCT06990880

Phase1, Phase2, Recruiting

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

for
Congenital Adrenal Hyperplasia,
Location: Rochester MN, Minneapolis MN, Milwaukee WI, Chicago IL,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07144163

Phase3, Recruiting

From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices

for
Foot Injury
Location: Rochester MN, Minneapolis MN, Iowa City IA,
Sponsor: Jason Wilken

Sex: All

Age: 18 - 65

Code: NCT06352788

Recruiting

The Co-Op @ HeartWorks

for
Congenital Heart Disease
Location: Rochester MN
Sponsor: HeartWorks, Inc.

Sex: All

Age: 0+

Code: NCT06469918

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Rochester MN, Minneapolis MN, Chippewa Falls WI,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

for
Chemotherapy-Related Nausea and/or Vomiting,
Location: Albert Lea MN, Mankato MN
Sponsor: Mayo Clinic

Sex: All

Age: 20+

Code: NCT05417867

Recruiting

Enhancing Brain And Mental Health Through Breathing Practice

for
Depressive Disorder, Anxiety, Adolescent
Location: Albert Lea MN, Eau Claire WI
Sponsor: Mayo Clinic

Sex: All

Age: 12 - 17

Code: NCT07369752

Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for
Colorectal Cancer
Location: Rochester MN, Minneapolis MN, Chicago IL, Ann Arbor MI,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07023289

Phase2, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Rochester MN, Milwaukee WI, Nashville TN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06158854

Phase1, Phase2, Recruiting